Seeing Is Believing
Currently out of the existing stock ratings of John Newman, 106 are a BUY (82.81%), 22 are a HOLD (17.19%).
Analyst John Newman works at CANACCORD with a stock forecast success ratio of 32.63% fulfilled within 98.04 days on average.
John Newman’s has documented 237 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ACLX, Arcellx at 29-Feb-2024.
Analyst best performing recommendations are on TSVT (2SEVENTY BIO).
The best stock recommendation documented was for ACLX (ARCELLX) at 4/19/2023. The price target of $40 was fulfilled within 5 days with a profit of $4.74 (13.44%) receiving and performance score of 26.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
$0.88 (3.02%)
32
1 months 6 days ago
3/3 (100%)
$-2.99 (-9.06%)
224
Hold
28
$-1.12 (-3.85%)
32
4 months 26 days ago
6/6 (100%)
$5.51 (24.50%)
192
Buy
42
$12.88 (44.23%)
67
9 months 2 days ago
5/12 (41.67%)
$13.87 (49.31%)
213
Buy
38
$8.88 (30.49%)
40
9 months 2 days ago
0/4 (0%)
$9.87 (35.09%)
Buy
37
$7.88 (27.06%)
33
1 years 7 months 24 days ago
6/11 (54.55%)
$7.26 (24.41%)
69
Which stock is John Newman is most bullish on?
Which stock is John Newman is most reserved on?
What Year was the first public recommendation made by John Newman?